Pharmaceutical PV DIV - FSB
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- SPE2DR25D3012
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Task orders
- 2,973 $28,419,003 obligated
Award facts
- Opportunity
-
- Pharmaceutical Prime Vendor Global GEN V Presolicitation Pre-Solicitation · SPE2DX24R0001 · Posted Feb 1, 2024
- Combined order value
- $28,419,003 Current and potential, with all options
- Last date to order 84% complete
- IDV ceiling 3% used
- $999,999,999.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The Indefinite Delivery Contract (IDC) SPE2DR25D3012 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $999,999,999 contract, which runs through December 2026, establishes AmerisourceBergen as a Pharmaceutical Prime Vendor to provide a comprehensive range of pharmaceutical products and medical supplies in support of military healthcare programs globally. This includes specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. The contract aims to ensure the DLA, Department of Defense, United States Coast Guard, and other government agencies have reliable access to vital pharmaceuticals during normal operations, contingencies, and disasters. The contract utilizes a Lowest Price Technically Acceptable (LPTA) evaluation methodology, with the government reserving the option to conduct a reverse auction to obtain the best possible distribution fees.
The IDC was awarded as part of the DLA Troop Support Medical's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) procurement, which seeks to establish multiple regional contracts to support DoD and other federal healthcare customers. The unrestricted, fully competitive solicitation is expected to have an estimated total value of $30.3 billion and will award at least three different contractors across the North/EUCOM, West/PACOM, South/SOUTHCOM, and Fleet regions. By diversifying the supplier base, the government aims to increase the resiliency and access to essential pharmaceuticals during times of contingency or natural disasters.
Task orders
Show 40 more
Latest 50 of 2,973 listed here. See the rest on GovTribe.
Quick answers
Who was awarded contract SPE2DR25D3012?
SPE2DR25D3012 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 13, 2025.
How much is contract SPE2DR25D3012 worth?
Orders under SPE2DR25D3012 have obligated $28,419,003. SPE2DR25D3012's own ceiling is $999,999,999.
How many orders have been placed under contract SPE2DR25D3012?
2,973 orders have been placed under SPE2DR25D3012, the latest on July 24, 2026.
Who can order from contract SPE2DR25D3012?
SPE2DR25D3012 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract SPE2DR25D3012 competed?
The extent of competition for SPE2DR25D3012 was full and open competition. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV